Morphology of a Bulk Heterojunction Photovoltaic Cell with Low Donor Concentration by Thomas Lee (414158)

“…Atomistic nonequilibrium molecular dynamics simulations have been used to model the morphology of small-molecule bulk heterojunction films formed by vapor deposition as used in organic photovoltaics. Films comprising C₆₀ and 1, 5, 10, and 50 wt % of 1,1-bis­[4-bis­(4-methylphenyl)­aminophenyl]­cyclohexane (TAPC) were compared to films of neat C₆₀. …”

Temporal trends of tuberculosis ASIR by Xue Li (285380)

BRD4 and LANA protein form LLPS. by Tomoki Inagaki (12903779)

Incidence, death and DALYs of TB, by age and sex in 2021. by Xue Li (285380)

LANA NBs functions as transcription memory. by Tomoki Inagaki (12903779)

Fatty acid alterations suggest Elovl4 may be elongating C26 and C28 fatty acids by D. Joshua Cameron (24488)

Image_4_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Image_7_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Table_2_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Table_3_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Image_2_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Image_1_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Image_6_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Table_1_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Image_3_HLA-C*04:01 Affects HLA Class I Heterozygosity and Predicted Affinity to SARS-CoV-2 Peptides, and in Combination With Age and Sex of Armenian Patients Contributes to COVID-... by Anahit Hovhannisyan (4382287)

“…In patients with clinical manifestation, due to the high prevalence of HLA-C*04:01, these effects provided a decrease of the HLA class-I heterozygosity and an ability to recognize SARS-CoV-2 peptides. …”

Spreadsheet for segmentation data. by Renxin Chu (5169857)

Late chronic DCS treatment has no effect on anxiolytic-like behavior or hypoactivity in adult <i>Grin2b</i>^{<i>+/C456Y</i>} mice. by Wangyong Shin (6793040)

Late acute DCS treatment has no effect on anxiolytic-like behavior or hypoactivity in adult <i>Grin2b</i>^{<i>+/C456Y</i>} mice. by Wangyong Shin (6793040)

Analysis of two putative toxin genes in the symbiotic island. by Julia Hahn (3279486)

Scatterplot showing the relationship between mean deviation (MD) and pattern standard deviation (PSD). by Dong Won Heo (3804817)